What is Rezolute, Inc.'s earnings per share (EPS)?

Rezolute, Inc. (RZLT) reported diluted earnings per share of -$0.98 for fiscal year 2025. This represents a 26.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Rezolute, Inc. (RZLT) Financials

RZLT

FY2025 annual

Revenue Not reported for FY2025

Net Income -$74.4M -8.7% YoY

EPS (Diluted) -$0.98 +26.3% YoY

Operating Cash Flow -$69.1M -20.5% YoY

Market Cap $409.2M as of Sep 15, 2026

Price / Sales n/m no revenue reported

Price / Earnings n/m net loss, so no earnings multiple, FY2025

Price / Book 3.5x on $116.8M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported May 12, 2026 Currency USD FYE June

Newest figures come from the 10-Q for Q3 FY2026, filed May 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RZLT SEC filings page.

This page shows Rezolute, Inc. (RZLT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score not available

Rezolute, Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

3/6

Rezolute, Inc. passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing

N/A

Rezolute, Inc. reported a net loss of $74.4M while operations used $69.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

EBITDA

-$17.4M

YoY+13.3%

QoQ+28.3%

Rezolute, Inc.'s EBITDA was -$17.4M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 13.3% from the same quarter a year earlier. Against the prior quarter it is up 28.3%.

Net Income

-$16.2M

YoY+14.5%

QoQ+29.0%

Rezolute, Inc. reported -$16.2M in net income in Q3 2026. This represents an increase of 14.5% from the same quarter a year earlier. Against the prior quarter it is up 29.0%.

EPS (Diluted)

-$0.16

YoY+40.7%

QoQ+27.3%

Rezolute, Inc. earned -$0.16 per diluted share (EPS) in Q3 2026. This represents an increase of 40.7% from the same quarter a year earlier. Against the prior quarter it is up 27.3%.

Revenue

Not reported for Q3 2026.

Cash & Balance Sheet

Cash & Debt

$11.2M

YoY-23.0%

QoQ-5.9%

5Y CAGR-18.9%

Rezolute, Inc. held $11.2M in cash as of Q3 2026; long-term debt is not reported for that period.

Shares Outstanding

96M

YoY+12.6%

QoQ+0.6%

5Y CAGR+63.1%

10Y CAGR+14.7%

Rezolute, Inc. had 96M shares outstanding in Q3 2026. This represents an increase of 12.6% from the same quarter a year earlier. Against the prior quarter it is up 0.6%.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Return on Equity

-13.8%

YoY+9.1pp

QoQ+4.0pp

Rezolute, Inc.'s ROE was -13.8% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is up 9.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 4.0 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not reported for Q3 2026.

Net Margin

Not reported for Q3 2026.

Capital Allocation

R&D Spending

$11.4M

YoY-25.3%

QoQ-20.5%

Rezolute, Inc. invested $11.4M in research and development in Q3 2026. This represents a decrease of 25.3% from the same quarter a year earlier. Against the prior quarter it is down 20.5%.

Share Buybacks

Not reported for Q3 2026.

Capital Expenditures

Not reported for Q3 2026.

RZLT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RZLT quarterly income statement

Metric	TTM	FY2510-Q	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
R&D Expenses	N/A	$61.5M+10.4%	$55.7M+27.2%	$43.8M+34.9%	$32.5M+116.8%	$15.0M+3.7%	$14.4M-24.3%	$19.1M	N/A	$12.1M+28.0%	$9.4M+101.0%	$4.7M+13599.4%	$34K+882.2%	$3K	$0	$0
SG&A Expenses	N/A	$18.4M+25.1%	$14.7M+20.6%	$12.2M+30.1%	$9.4M+18.3%	$7.9M+30.2%	$6.1M-11.6%	$6.9M-24.6%	$9.1M+10.6%	$8.2M+49.5%	$5.5M-8.2%	$6.0M+16.6%	$5.1M+17840.4%	$29K-32.8%	$43K+93.3%	$22K
Operating Income	N/A	-$79.9M-13.4%	-$70.4M-25.8%	-$56.0M-33.8%	-$41.8M-82.8%	-$22.9M-11.6%	-$20.5M+20.9%	-$25.9M	N/A	-$20.3M-35.9%	-$15.0M-39.8%	-$10.7M-106.7%	-$5.2M	N/A	N/A	-$393K
EBITDA	N/A	-$79.9M-13.5%	-$70.4M-25.8%	-$56.0M-33.8%	-$41.8M-82.8%	-$22.9M-11.6%	-$20.5M+20.8%	-$25.9M	N/A	-$19.2M-35.3%	-$14.2M-34.4%	-$10.6M-104.5%	-$5.2M	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	$1.8M+381.9%	$375K	$0-100.0%	$5.0M+619.6%	$689K+43097.5%	$2K-68.3%	$5K-25.1%	$7K-99.8%	$4.2M+643.6%	$569K	N/A	$204K
Income Tax	N/A	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	N/A	$0
Net Income	N/A	-$74.4M-8.7%	-$68.5M-32.2%	-$51.8M-26.1%	-$41.1M-96.4%	-$20.9M-2.8%	-$20.3M+33.2%	-$30.4M	N/A	-$20.3M-35.8%	-$14.9M-31.4%	-$11.4M-16.8%	-$9.7M	N/A	-$783K-32.7%	-$590K
EPS (Basic)	N/A	-$0.98+26.3%	-$1.33-31.7%	-$1.01+55.3%	-$2.26+16.9%	-$2.72	N/A	N/A	N/A	N/A	N/A	N/A	-$1.04+3.7%	-$1.08	N/A	-$0.02
EPS (Diluted)	-$0.82	-$0.98+26.3%	-$1.33-31.7%	-$1.01	-$2.32	-$2.72	N/A	N/A	N/A	N/A	N/A	N/A	-$1.04	-$1.08	N/A	-$0.02
Diluted Shares (Avg)	N/A	76M+47.7%	51M+0.5%	51M	19M	8M	N/A	N/A	N/A	N/A	N/A	N/A	9M	6M	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
R&D Expenses	$11.4M-25.3%	$14.3M+13.6%	$13.1M+3.1%	N/A	$15.3M+23.2%	$12.6M+4.9%	$12.8M+4.4%	N/A
SG&A Expenses	$6.0M+25.6%	$9.9M+121.7%	$6.7M+59.3%	N/A	$4.7M+24.3%	$4.5M+41.1%	$4.2M+13.2%	N/A
Operating Income	-$17.4M+13.3%	-$24.2M-41.8%	-$19.8M-17.0%	N/A	-$20.0M-23.5%	-$17.1M-12.4%	-$16.9M-6.5%	N/A
EBITDA	-$17.4M+13.3%	-$24.2M-41.8%	-$19.8M-17.0%	N/A	-$20.0M-23.5%	-$17.1M-12.4%	-$16.9M-6.5%	N/A
Net Income	-$16.2M+14.5%	-$22.8M-44.8%	-$18.1M-18.0%	N/A	-$18.9M-10.9%	-$15.7M-13.1%	-$15.4M-5.9%	N/A
EPS (Basic)	-$0.16+40.7%	-$0.220.0%	-$0.18+18.2%	-$0.26+40.9%	-$0.27+20.6%	-$0.22+18.5%	-$0.22+21.4%	-$0.44-76.0%
EPS (Diluted)	-$0.16+40.7%	-$0.220.0%	-$0.18+18.2%	-$0.26+40.9%	-$0.27	-$0.22+18.5%	-$0.22+21.4%	-$0.44-76.0%
Diluted Shares (Avg)	104M+48.6%	104M+48.3%	103M+48.3%	N/A	70M	70M+36.0%	70M+35.6%	N/A

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Interest Expense, Income Tax.

RZLT Balance Sheet

RZLT quarterly balance sheet

Metric	FY2510-Q	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$175.5M+32.2%	$132.7M+7.3%	$123.7M-18.8%	$152.4M+257.7%	$42.6M+288.6%	$11.0M-10.5%	$12.3M+389.5%	$2.5M-76.5%	$10.6M-2.5%	$10.9M-3.2%	$11.3M+52.1%	$7.4M+570.7%	$1.1M+3.3%	$1.1M+88.9%	$566K
Current Assets	$171.1M+33.0%	$128.7M+22.6%	$104.9M-31.0%	$152.1M+262.2%	$42.0M+299.2%	$10.5M-13.4%	$12.1M+504.8%	$2.0M-59.3%	$4.9M+9.7%	$4.5M-26.6%	$6.1M-3.0%	$6.3M+673.4%	$816K-23.7%	$1.1M+88.9%	$566K
Cash & Equivalents	$94.1M+33.7%	$70.4M+339.0%	$16.0M-89.3%	$150.4M+266.4%	$41.0M	N/A	N/A	$1.6M-63.3%	$4.5M+10.5%	$4.1M-23.0%	$5.3M-11.1%	$5.9M+1125997.5%	$527-98.0%	$26K+3905.9%	$646
Short-Term Investments	$73.8M+30.6%	$56.5M-34.2%	$85.9M	$0	$0	N/A	N/A	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$67K-76.8%	$290K+29.9%	$223K	$0	$0
Long-Term Investments	$0-100.0%	$263K-98.4%	$16.5M	$0	$0	N/A	N/A	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$13.4M+13.9%	$11.7M+55.4%	$7.5M+156.0%	$2.9M-82.1%	$16.5M+358.6%	$3.6M-65.7%	$10.5M+62.4%	$6.5M+207.7%	$2.1M-1.4%	$2.1M-3.6%	$2.2M+121.4%	$998K-81.1%	$5.3M+123.4%	$2.4M+61.9%	$1.5M
Current Liabilities	$11.9M+24.0%	$9.6M+84.7%	$5.2M+111.2%	$2.5M+25.1%	$2.0M-39.0%	$3.2M-61.5%	$8.4M+34.1%	$6.2M+252.7%	$1.8M+2.4%	$1.7M+1.4%	$1.7M+76.9%	$964K-81.7%	$5.3M+123.4%	$2.4M+68.2%	$1.4M
Non-Current Liabilities	$1.5M-31.8%	$2.1M-9.4%	$2.3M+382.3%	$487K-96.7%	$14.5M+3788.2%	$374K-82.4%	$2.1M+883.7%	$216K-34.6%	$330K-17.6%	$400K-20.6%	$504K+1386.4%	$34K	$0	$0-100.0%	$55K
Long-Term Debt	N/A	N/A	N/A	N/A	$14.0M	$0	$0-100.0%	$3.4M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$162.1M+34.0%	$121.0M+4.2%	$116.2M-22.3%	$149.5M+472.7%	$26.1M+254.4%	$7.4M+320.4%	$1.8M+144.2%	-$4.0M-146.4%	$8.5M-2.8%	$8.8M-3.1%	$9.1M+41.3%	$6.4M+253.9%	-$4.2M-222.9%	-$1.3M-44.7%	-$891K
Retained Earnings	-$403.9M-22.6%	-$329.4M-26.2%	-$261.0M-24.8%	-$209.2M-24.4%	-$168.1M-14.2%	-$147.2M-16.0%	-$126.9M-34.7%	-$94.2M-46.4%	-$64.3M-46.0%	-$44.0M-51.3%	-$29.1M-64.0%	-$17.7M	N/A	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Total Assets	$125.5M+32.4%	$138.6M+23.8%	$158.7M+28.6%	$175.5M+32.2%	$94.7M+8.0%	$112.0M+9.6%	$123.4M+9.2%	$132.7M+7.3%
Current Assets	$122.0M+37.5%	$135.1M+36.9%	$154.7M+40.4%	$171.1M+33.0%	$88.7M+7.9%	$98.7M+2.7%	$110.2M+7.3%	$128.7M+22.6%
Cash & Equivalents	$11.2M-23.0%	$11.9M+33.7%	$9.1M-13.1%	$94.1M+33.7%	$14.6M+146.1%	$8.9M-28.6%	$10.5M+30.0%	$70.4M+339.0%
Short-Term Investments	$109.0M+50.8%	$121.0M+38.1%	$143.1M+46.3%	$73.8M+30.6%	$72.3M-2.4%	$87.6M+9.4%	$97.8M+7.9%	$56.5M-34.2%
Long-Term Investments	$0-100.0%	$0-100.0%	$0-100.0%	$0-100.0%	$1.5M-3.8%	$8.8M+161.8%	$9.6M+17.3%	$263K-98.4%
Total Liabilities	$8.6M-29.1%	$10.6M-14.4%	$11.5M+15.3%	$13.4M+13.9%	$12.2M-27.9%	$12.4M+19.2%	$10.0M+5.7%	$11.7M+55.4%
Current Liabilities	$7.7M-26.8%	$9.5M-10.2%	$10.2M+27.8%	$11.9M+24.0%	$10.5M+51.3%	$10.6M+32.5%	$8.0M+11.1%	$9.6M+84.7%
Non-Current Liabilities	$921K-43.9%	$1.1M-39.1%	$1.3M-35.1%	$1.5M-31.8%	$1.6M-83.4%	$1.8M-25.0%	$2.0M-11.5%	$2.1M-9.4%
Total Equity	$116.8M+41.5%	$128.0M+28.5%	$147.2M+29.7%	$162.1M+34.0%	$82.6M+16.5%	$99.6M+8.6%	$113.4M+9.5%	$121.0M+4.2%
Retained Earnings	-$461.0M-21.5%	-$444.8M-23.4%	-$422.0M-22.4%	-$403.9M-22.6%	-$379.5M-23.8%	-$360.6M-24.6%	-$344.8M-25.2%	-$329.4M-26.2%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

RZLT Cash Flow Statement

RZLT quarterly cash flow statement

Metric	TTM	FY2510-Q	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$73.5M	-$69.1M-20.5%	-$57.4M-29.0%	-$44.5M-12.3%	-$39.6M-93.8%	-$20.4M+15.4%	-$24.2M-57.9%	-$15.3M	N/A	-$13.3M-26.9%	-$10.5M-48.2%	-$7.1M-123.5%	-$3.2M-94.6%	-$1.6M-3929.8%	-$40K+88.9%	-$363K
Depreciation & Amortization	N/A	$31K-13.9%	$36K+20.0%	$30K+130.8%	$13K0.0%	$13K-27.8%	$18K-63.3%	$49K-95.4%	$1.1M-4.3%	$1.1M+48.3%	$751K+460.1%	$134K+1086.6%	$11K+3731.5%	$295	N/A	N/A
Stock-Based Compensation	N/A	$7.1M-3.2%	$7.4M+1.3%	$7.3M+97.2%	$3.7M-7.1%	$4.0M+19.5%	$3.3M+25.8%	$2.6M-48.3%	$5.1M-15.2%	$6.0M+59.6%	$3.8M+32.1%	$2.8M+163.2%	$1.1M-70.7%	$3.7M	N/A	$0
Capital Expenditures	N/A	N/A	N/A	$153K	N/A	N/A	$0-100.0%	$47K+683.3%	$6K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	-$44.6M	N/A	N/A	-$24.2M-57.4%	-$15.4M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$33.0M	-$14.5M-129.9%	$48.7M+148.0%	-$101.5M	N/A	$0	$0-100.0%	$231K-86.7%	$1.7M+986.5%	-$195K	N/A	N/A	N/A	$185K+9355.7%	-$2K+99.5%	-$414K
Financing Cash Flow	$103.2M	$107.3M+70.3%	$63.0M+444.7%	$11.6M-92.2%	$149.0M+189.1%	$51.5M+128.5%	$22.6M-9.8%	$25.0M+162.1%	$9.5M-31.5%	$13.9M	N/A	N/A	N/A	$1.4M+13400.0%	$11K-98.6%	$778K
Share Buybacks	N/A	N/A	$3K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Operating Cash Flow	-$13.7M+21.1%	-$20.3M-48.7%	-$17.4M-8.8%	-$22.0M-18.9%	-$17.4M-14.2%	-$13.7M-5.0%	-$16.0M-51.3%	-$18.5M-63.2%
Depreciation & Amortization	$8K+14.3%	$7K-12.5%	$8K0.0%	$8K+14.3%	$7K-22.2%	$8K-20.0%	$8K-20.0%	$7K-22.2%
Stock-Based Compensation	$4.4M+132.0%	$3.4M+136.1%	$2.5M+80.8%	N/A	$1.9M+0.1%	$1.4M-21.3%	$1.4M-24.3%	N/A
Investing Cash Flow	$12.3M-46.7%	$22.8M+98.9%	-$68.5M-38.6%	$346K-98.2%	$23.1M+165.9%	$11.5M-35.4%	-$49.4M-1996.0%	$19.7M+409.3%
Financing Cash Flow	$747K+7370.0%	$356K-45.8%	$911K-83.4%	$101.2M+59.7%	$10K+433.3%	$657K	$5.5M	$63.3M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid.

RZLT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RZLT quarterly financial ratios

Metric	FY2510-Q	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Return on Equity	-45.9%+10.7pp	-56.6%-12.0pp	-44.6%-17.1pp	-27.5%+52.6pp	-80.1%+196.0pp	-276.1%+1461.7pp	-1737.8%	N/A	-237.8%-67.5pp	-170.3%-44.8pp	-125.5%+26.4pp	-151.9%	N/A	N/A	N/A
Return on Assets	-42.4%+9.2pp	-51.6%-9.7pp	-41.9%-14.9pp	-26.9%+22.1pp	-49.1%+136.4pp	-185.4%+63.1pp	-248.5%	N/A	-190.8%-53.8pp	-137.0%-36.1pp	-100.9%+30.5pp	-131.4%	N/A	-73.3%+31.0pp	-104.3%
Current Ratio	14.37+1.0x	13.39-6.8x	20.18-41.6x	61.78+40.4x	21.34+18.1x	3.26+1.8x	1.45+1.1x	0.32-2.5x	2.78+0.2x	2.60-1.0x	3.59-3.0x	6.54+6.4x	0.15-0.3x	0.450.0x	0.40
Debt-to-Equity	0.080.0x	0.100.0x	0.070.0x	0.02-0.5x	0.54+0.5x	0.000.0x	0.00	N/A	0.250.0x	0.240.0x	0.24+0.1x	0.16	N/A	N/A	N/A

Metric	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K
Return on Equity	-13.8%+9.1pp	-17.8%-2.0pp	-12.3%+1.2pp	N/A	-22.9%+1.2pp	-15.8%-0.6pp	-13.6%+0.5pp	N/A
Return on Assets	-12.9%+7.1pp	-16.4%-2.4pp	-11.4%+1.0pp	N/A	-20.0%-0.5pp	-14.0%-0.4pp	-12.5%+0.4pp	N/A
Current Ratio	15.84+7.4x	14.18+4.9x	15.15+1.4x	14.37+1.0x	8.43-3.4x	9.30-2.7x	13.79-0.5x	13.39-6.8x
Debt-to-Equity	0.07-0.1x	0.080.0x	0.080.0x	0.080.0x	0.15-0.1x	0.120.0x	0.090.0x	0.100.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Rezolute, Inc. RZLT	FY2025	N/A	-$74.4M	N/A	$409.2M	—
Rigel Pharmaceuticals Inc. (New) RIGL	FY2025	$294.3M	$367.0M	N/A	$882.4M	62/100
KalVista Pharmaceuticals, Inc. KALV	FY2025	N/A	-$183.4M	N/A	$1.4B	—
Vir Biotechnology, Inc. VIR	FY2025	$68.6M	-$438.0M	N/A	$1.8B	66/100
Relay Therapeutics, Inc. RLAY	FY2025	$15.4M	-$276.5M	N/A	$4.1B	49/100
Theravance Biopharma, Inc. TBPH	FY2025	$107.5M	$105.9M	98.5%	$883.1M	76/100

Where Rezolute, Inc. Ranks

Frequently Asked Questions

Is Rezolute, Inc. profitable?

No, Rezolute, Inc. (RZLT) reported a net income of -$74.4M in fiscal year 2025.

What is Rezolute, Inc.'s EBITDA?

Rezolute, Inc. (RZLT) had EBITDA of -$79.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Rezolute, Inc.'s return on equity (ROE)?

Rezolute, Inc. (RZLT) has a return on equity of -45.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Rezolute, Inc.'s operating cash flow?

Rezolute, Inc. (RZLT) recorded an outflow of $69.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Rezolute, Inc.'s total assets?

Rezolute, Inc. (RZLT) had $175.5M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Rezolute, Inc. spend on research and development?

Rezolute, Inc. (RZLT) invested $61.5M in research and development during fiscal year 2025.

How many shares does Rezolute, Inc. have outstanding?

Rezolute, Inc. (RZLT) had 91M shares outstanding as of fiscal year 2025.

What is Rezolute, Inc.'s current ratio?

Rezolute, Inc. (RZLT) had a current ratio of 14.37 as of fiscal year 2025, which is generally considered healthy.

What is Rezolute, Inc.'s debt-to-equity ratio?

Rezolute, Inc. (RZLT) had a debt-to-equity ratio of 0.08 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Rezolute, Inc.'s return on assets (ROA)?

Rezolute, Inc. (RZLT) had a return on assets of -42.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Rezolute, Inc.'s P/E ratio?

Rezolute, Inc. (RZLT) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $409.2M as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Rezolute, Inc.'s price-to-sales ratio?

Rezolute, Inc. (RZLT) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $409.2M as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does Rezolute, Inc.'s liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Rezolute, Inc. (RZLT) held $167.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $69.1M over that year. Dividing the one by the other, the reported balance equals about 29 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Rezolute, Inc.'s Piotroski F-Score?

Rezolute, Inc. (RZLT) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Rezolute, Inc.'s earnings high quality?

Rezolute, Inc. (RZLT) reported a net loss of $74.4M while operations used $69.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.